Dr. Yi Lu has developed a point-of-contact device for the portable and affordable detection of molecules important in physiology and disease. This technology, based on...
Dr. Yi Lu has developed a point-of-contact device for the portable and affordable detection of molecules important in physiology and disease. This technology, based on highly specific nucleotide molecules known as DNAzymes, can detect physiological levels of metal ions such as sodium and lithium, which play an important role in bipolar disease. A modification of this technology, based on DNA molecules known as aptamers, can be adapted to detect the food adulterant melamine, which has resulted in death of thousands of infants and pets. Detection of these molecules can be performed at home with the commercially available glucose meters.
Dr. John Rogers from the University of Illinois at Urbana-Champaign has developed bioresorbable silicon electronics that can be used for real-time sensing of neural...
Dr. John Rogers from the University of Illinois at Urbana-Champaign has developed bioresorbable silicon electronics that can be used for real-time sensing of neural electrical activity. This invention could prevent follow-up neural surgeries, and has potentials for long-term monitoring of patients.
Dr. Andrew Smith from the University of Illinois has developed new quantum dots with a multidentate polymer coating that minimizes size while maintaining stability and...
Dr. Andrew Smith from the University of Illinois has developed new quantum dots with a multidentate polymer coating that minimizes size while maintaining stability and improving efficiency of conjugation. Quantum dots are promising agents for cellular and molecular imaging, but their bulky organic coatings have limited their use in cells. Dr. Smith's quantum dots are small, stable, and can be conjugated to targeting molecules and purified easily.
Dr. Hergenrother from the University of IL has developed a novel antibiotic that is effective against certain antibiotic-resistant gram-negative bacteria. His powerful...
Dr. Hergenrother from the University of IL has developed a novel antibiotic that is effective against certain antibiotic-resistant gram-negative bacteria. His powerful predictive algorithm determines accumulation of molecules in Gram-negative bacteria and enables conversion of known Gram-positive only antibiotics into novel compounds with Gram-negative potency.
